Clinical Practice Guidelines
2.0.0-ballot - ballot International flag

This page is part of the Clinical Guidelines (v2.0.0-ballot: STU2 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. The current version which supersedes this version is 1.0.0. For a full list of available versions, see the Directory of published versions

Example PlanDefinition: CHF LASIX Recommendation

Active as of 2023-12-19

Generated Narrative: PlanDefinition

Resource PlanDefinition "chf-lasix"

Profile: CPG Recommendation Definition

CQF Knowledge capability: shareable

CQF Knowledge capability: computable

CQF Knowledge capability: publishable

CQF knowledge representation level: structured

CPG Part Of Extension: CHFHypervolemia

CPG Enabled Extension: true

StructureDefinition Work Group: cds

url: http://hl7.org/fhir/uv/cpg/PlanDefinition/chf-lasix

version: 2.0.0-ballot

name: CHFLASIX

type: ECA Rule (PlanDefinitionType#eca-rule)

status: active

experimental: true

date: 2023-12-19 19:53:17+0000

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss

description: Administer LASIX IV, transition to PO as appropriate

jurisdiction: World (m49.htm#001)

Goals

-DescriptionStart
*Transition to LASIX PO ()Admission to hospital (SNOMED CT#32485007)

action

id

lasix-iv

title: LASIX IV

description: Administer LASIX IV

code: Dispense Medications (CPG Common Process Code System#dispense-medications)

condition

kind: stop

Expressions

-LanguageExpression
*text/cql-identifierShould Stop LASIX IV

definition: CHFLASIXIV

action

id

lasix-po

title: LASIX PO

description: Administer LASIX PO

code: Dispense Medications (CPG Common Process Code System#dispense-medications)

condition

kind: start

Expressions

-LanguageExpression
*text/cql-identifierShould Start LASIX PO

definition: CHFLASIXPO